Search Within

David G Pfister

  1. "Genitourinary Oncology Service"
Formats
  1. Journal Article (20)
  2. Meeting Abstract (9)
  3. Research Letter (1)
Groups
  1. Department of Medicine (30)
  2. Genitourinary Oncology Service (30)
  3. Head and Neck Service (30)
  4. Solid Tumor Oncology Division (30)
  5. Neuroradiology Service (16)
  6. Radiology, Department of (16)

More Groups

People
  1. Matthew Fury (18)
  2. Eric Sherman (16)
  3. Nancy Lee (13)
  4. Han Xiao (12)
  5. Alan Ho (11)
  6. Shrujal Baxi (10)

More People

Years
  1. 2020 (1)
  2. 2019 (1)
  3. 2018 (1)
  4. 2017 (3)
  5. 2016 (1)
  6. 2015 (1)

More Years

Publications
  1. Journal of Clinical Oncology (11)
  2. International Journal of Radiation Oncology, Biology, Physics (5)
  3. Cancer (3)
  4. Head & Neck (2)
  5. Investigational New Drugs (2)
  6. Annals of Oncology (1)

More Publications

Publishers
  1. American Society of Clinical Oncology (11)
  2. Elsevier Inc. (5)
  3. Springer (3)
  4. Wiley Blackwell (3)
  5. American Medical Association (2)
  6. John Wiley & Sons, Inc. (2)

More Publishers

Results (30)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • A phase 1 study of everolimus plus docetaxel plus cisplatin as induction chemotherapy for patients with locally and/or regionally advanced head and neck cancer
    Journal Article

    Fury, M. G.; Sherman, E.; Ho, A. L.; Xiao, H.; Tsai, F.; Nwankwo, O.; Sima, C.; Heguy, A.; Katabi, N.; Haque, S.; more...
    Cancer (2013)

    Fulltext@MSK | Save
  • A phase II study of temsirolimus/sorafenib in patients with radioactive iodine (RAI)-refractory thyroid carcinoma
    Meeting Abstract

    Sherman, E. J.; Ho, A. L.; Fury, M. G.; Baxi, S. S.; Haque, S.; Korte, S. H.; Smith-Marrone, S.; Xiao, H.; Ghossein, R. A.; Fagin, J. A.; more...
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • A randomized phase II study of cetuximab every 2 weeks at either 500 or 750 mg/m2 for patients with recurrent or metastatic head and neck squamous cell cancer
    Journal Article

    Fury, M. G.; Sherman, E.; Lisa, D.; Agarwal, N.; Algazy, K.; Brockstein, B.; Langer, C.; Lim, D. ; Mehra, R.; Rajan, S. K.; more...
    Journal of the National Comprehensive Cancer Network (2012)

    Fulltext@MSK | Save
  • Dynamic contrast-enhanced magnetic resonance imaging as a predictor of outcome in head-and-neck squamous cell carcinoma patients with nodal metastases
    Journal Article

    Shukla-Dave, A.; Lee, N. Y.; Jansen, J. F. A.; Thaler, H. T.; Stambuk, H. E.; Fury, M. G.; Patel, S. G.; Moreira, A. L.; Sherman, E.; Karimi, S.; more...
    International Journal of Radiation Oncology, Biology, Physics (2012)

    Fulltext@MSK | Save
  • Tumor metabolism and perfusion in head and neck squamous cell carcinoma: Pretreatment multimodality imaging with (1)H magnetic resonance spectroscopy, dynamic contrast-enhanced MRI, and [(18)F]FDG-PET
    Journal Article

    Jansen, J. F. A.; Schoder, H.; Lee, N. Y.; Stambuk, H. E.; Wang, Y.; Fury, M. G.; Patel, S. G.; Pfister, D. G.; Shah, J. P.; Koutcher, J. A.; more...
    International Journal of Radiation Oncology, Biology, Physics (2012)

    Fulltext@MSK | Save
  • A randomized phase II study of cetuximab (C) every 2 weeks at either 500 or 750 mg/m(2) for patients (Pts) with recurrent or metastatic (R/M) head and neck squamous cell cancer (HNSCC)
    Meeting Abstract

    Fury, M. G.; Sherman, E. J.; Lisa, D. M.; Agarwal, N.; Algazy, K. M.; Brockstein, B.; Langer, C. J.; Lim, D.; Mehra, R.; Rajan, S. K.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Noninvasive assessment of tumor microenvironment using dynamic contrast-enhanced magnetic resonance imaging and (18)F-fluoromisonidazole positron emission tomography imaging in neck nodal metastases
    Journal Article

    Jansen, J. F. A.; Schoder, H.; Lee, N. Y.; Wang, Y.; Pfister, D. G.; Fury, M. G.; Stambuk, H. E.; Humm, J. L.; Koutcher, J. A.; Shukla-Dave, A.
    International Journal of Radiation Oncology, Biology, Physics (2010)

    Fulltext@MSK | Save
  • Correlation of dynamic contrast enhanced magnetic resonance imaging (DCE MRI) with (18)f-fluoromisonidazole positron emission and computed tomography ((18)F-FMISO PET/CT) in assessing tumor hypoxia in a series of head and neck cancer (HNC) patients with nodal metastases
    Meeting Abstract

    Lee, N.; Jensen, J.; Schoder, H.; Wang, Y.; Fury, M.; Pfister, D. G.; Stambuk, H.; Humm, J.; Koutcher, J.; Shukla-Dave, A.
    Journal of Clinical Oncology (2009)

    Fulltext@MSK | Save
  • Dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) as a predictor of response in head and neck squamous cell carcinoma (HNSCC)
    Meeting Abstract

    Dave, A.; Fury, M.; Lee, N.; Stambuk, H.; Wang, Y.; Karimi, S.; Pfister, D.; Koutcher, J.
    Journal of Clinical Oncology (2007)

    Fulltext@MSK | Save
  • Dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) as a predictor of response in head and neck squamous cell carcinoma (HNSCC): Initial analysis
    Meeting Abstract

    Shukla-Dave, A.; Lee, N.; Wang, Y.; Stambuk, H.; Karimi, S.; Shah, J. P.; Pfister, D. G.; Koutcher, J. A.
    International Journal of Radiation Oncology, Biology, Physics (2007)

    Fulltext@MSK | Save